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The study was carried out to investigate the oncolytic effect of Newcastle 
disease virus (NDV) strain AF2240 on the MCF-7, MDA-MB-231 breast cancer 
cell lines and 3T3 fibroblast. Studies were conducted to investigate the 
cytoskeletal protein structure and the molecular changes of the oncogenes. The 
AF2240 strain of NDV was propagated in 11 days old embryonated eggs for 72 
hours. The virus in the allantoic fluid was harvested, purified and stored at          
-80ºC. The haemagglutination (HA) test was conducted on the purified virus to 
determine the HA titre of the NDV strain AF2240 which was 16384 HA units. 
The inhibition concentration of AF2240 towards several types of breast cancer 
cell lines was carried out using microculture tetrazolium (MTT) assay via two 
methods; monolayer and co-culture techniques to determine the inhibition 
concentration (IC50) value. The IC50 values for MDA-MB-231 breast cancer cell 
 iii
lines treated with NDV strain AF2240 were 8 and 2 HA units for the monolayer 
and co-culture techniques respectively, whereas the IC50 value for MCF-7 was 2 
HA units for both techniques. NDV strain AF2240 has no oncolytic effect 
towards 3T3 mouse fibroblast. Further on confocal microscopy was carried out 
to observe the localization of the virus in the cells. For detection of the virus, 
polyclonal antibody and anti-chicken conjugated with fluorescein isothiocynate 
(FITC) were used. The virus particles were detected in the cytoplasm of both 
breast cancer cell lines after 24 and 48 hours post treatment. Budding-off of the 
virus was detected after 72 hours post treatment.  Further study using TdT- 
mediated dUTP nick-end labelling (TUNEL) assay was conducted to label and 
quantify the percentage of apoptotic cells. By using independent t-test, the 
analysis revealed that NDV strain AF2240 works better towards MDA-MB-231 
cells compared to MCF-7 (p ≤ 0.05). These methods confirmed that NDV causes 
cell death to the breast cancer cells via apoptosis. The finding also suggesting 
that NDV react better towards MDA-MB-231 cells compared to MCF-7 cell 
(P≤0.05). The immunolabelling of the cytoskeletal proteins, namely, 
microfilaments, microtubules and intermediate filaments was conducted by 
using FL Phallicidin, monoclonal anti-α-tubulin FITC and monoclonal anti-
vimentin Cy3. The cytoskeletal proteins of the cell lines were disrupted after 72 
hours post treatment. However, the number of cells with disrupted cytoskeletal 
proteins was much higher in MDA-MB-231 cells compared to MCF-7 cells. The 
study of oncogenes was conducted by using reverse transcriptase polymerase 
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chain reaction (RT-PCR) method. The expressions of c-myc, c-erb-2 and c-fos 
oncogenes were detected at pre and post-treatment in the MCF-7 and MDA-MB-
231 breast cancer cell lines. These results prove that cells which had undergone 
apoptosis due to NDV strain AF2240 treatment did not suppress the oncogenes. 
This study concluded that even though strain AF2240 of NDV have significant 
cytotoxic effect towards MCF-7 breast cancer cell lines, the number of apoptotic 
cells were higher in MDA-MB-231 cell line and therefore, further study is 
needed to understand the underlying mechanism  in making the NDV strain of 
AF2240 as an anti-cancer agent.  
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Kajian ini dijalankan untuk menyelidik kesan onkolitik virus penyebab 
Newcastle disease (NDV) strain AF2240 ke atas sel kanser payudara MCF-7, 
MDA-MB-231 dan 3T3 fibroblast. Kajian ini dijalankan untuk menyelidik 
perubahan strukur protein sitoskeletal dan perubahan molekular onkogen. 
Propagasi NDV telah dilakukan di dalam telur ayam berembrio berusia 11 hari 
selama 72 jam. Virus yang terdapat dalam cecair alantoik kemudiannya 
dikumpul, ditulenkan dan disimpan pada -80ºC. Ujian penggumpalan (HA) 
telah dijalankan ke atas virus yang telah ditulenkan untuk menentukan titer HA  
virus NDV strain AF2240 yang mana HA unitnya ialah 16384. Kesan NDV 
AF2240 ke atas sel kanser payudara telah dilakukan mengguna kaedah 
mikrokultur tetrazolium (MTT) esei melalui dua cara; teknik monolayer dan ko-
kultur untuk menentukan nilai IC50. Nilai IC50 untuk sel payudara MDA-MB-231 
yang dirawat dengan NDV strain AF2240 adalah masing-masing 8 dan 2 HA 
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unit untuk teknik monolayer dan ko-kultur, manakala nilai IC50 untuk MCF-7 
adalah 2 HA unit untuk kedua-dua teknik. NDV strain AF2240 tidak 
mempunyai kesan onkolitik terhadap sel fibroblast 3T3. Kajian selanjutnya telah 
dilakukan dengan menggunakan mikroskop konfokal untuk melihat taburan 
virus tersebut di dalam sel. Untuk mengesan virus tersebut, antibodi poliklonal 
dan anti-ayam fluorescein isothiocynate (FITC) telah digunakan. Virus tersebut 
telah dikesan di dalam sitoplasma kedua-dua jenis sel payudara selepas dirawat 
selama 24 dan 48 jam. Walaubagaimanapun, pelepasan virus dari sel perumah 
selepas 72 jam dirawat hanya dapat dikesan di dalam sel kanser payudara. 
Kajian selanjutnya menggunakan asai TdT- mediated dUTP nick-end labelling 
(TUNEL) telah dijalankan untuk melabel dan mengira peratusan sel apoptotik. 
Dengan menggunakan ujian-t berdikari, analisis menunjukkan bahawa NDV 
strain AF2240 bertindak balas lebih baik terhadap sel MDA-MB-231 
dibandingkan dengan MCF-7 (p ≤ 0.05). Cara ini mengesahkan bahawa NDV 
menyebabkan sel payudara mati melalui apoptosis. Kajian ini juga 
mencadangkan bahawa NDV bertindak balas lebih baik terhadap sel MDA-MB-
231 berbanding dengan MCF-7 (P≤0.05). Penglabelan imuno ke atas protein 
sitoskeletal seperti filamenmikro, tubulmikro dan filamen pertengahan telah 
dijalankan dengan menggunakan FL Phallicidin,   monoklonal anti-α-tubulin 
FITC dan monoklonal anti-vimentin Cy3. Protin sitoskeletal sel rosak selepas 72 
jam dirawat. Walau bagaimanapun, jumlah sel yang mengalami kerosakan 
protein sitoskeletal lebih tinggi di dalam sel MD-MB-231 berbanding sel MCF-7. 
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Kajian mengenai onkogen dilakukan menggunakan kaedah ‘reverse 
transcriptase polymerase chain reaction’ (RT-PCR). Ekpresi c-myc, c-erb-2 dan c-
fos onkogen telah dikesan sebelum dan selepas rawatan di dalam sel MCF-7 dan 
MDA-MB-231. Keputusan ini menunjukkan bahawa apoptosis yang di sebabkan 
NDV strain AF2240 tidak menindas onkogen. Kajian ini menyimpulkan 
bahawa, walaupun NDV strain AF2240 mempunyai lebih kesan sitotoksik 
terhadap sel MCF-7, sel MDA-MB-231 mempunyai bilangan sel apoptotic yang 
lebih banyak dan dengan itu kajian yang lebih mendalam diperlukan untuk 
memahami mekanisma yang terselindung dalam menjadikan NDV strain 
AF2240 sebagai agen anti-kanser. 
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